Access earnings results, analyst expectations, report, slides, earnings call, and transcript.

The earnings report shows a mix of positive and negative factors. While there are strong adjusted earnings, revenue growth, and shareholder returns, net derivative losses and less favorable underwriting in Asia present concerns. The acquisition of PineBridge and strong PRT transactions are positive, but integration risks exist. The market may react cautiously, resulting in a neutral stock price movement.
The earnings call reveals strong financial performance, especially in the PRT business and Asian markets. Shareholder returns are robust, with substantial buybacks and dividends. Despite macroeconomic challenges in Japan, the company maintains a strong position with positive sales growth. The Q&A section highlights resilience against risks, such as AI and macroeconomic volatility, and identifies growth opportunities like PFML. The positive sentiment is reinforced by optimistic guidance and strategic initiatives, suggesting a likely positive stock price movement over the next two weeks.
The earnings call highlights strong performance and strategic advancements, such as the successful Chariot Re launch and favorable financial ratios. The Q&A session reveals management's confidence in overcoming challenges, with positive updates on nonmedical health and MIM's growth. Despite some unclear responses, the overall sentiment is positive due to strategic initiatives like the PineBridge acquisition and efficient capital structures in Japan. The stock price is likely to experience a positive movement, within the 2% to 8% range, as the company demonstrates resilience and growth potential.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.